Weill Cornell Medicine Oncology & Hematology
Tailoring Therapies to Target Leukemia Stem Cells: PU-FITC Binding Assay Could Be Utilized to Select Patients That Are More Likely to Respond to Treatment With PUH71
Comments 0
Login to view comments.
Click here to Login
